<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03712046</url>
  </required_header>
  <id_info>
    <org_study_id>18.200</org_study_id>
    <nct_id>NCT03712046</nct_id>
  </id_info>
  <brief_title>Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis</brief_title>
  <official_title>Comparaison Entre la Performance du 18F-FDG PET/CT et de la Scintigraphie Osseuse/Gallium ou de la Scintigraphie Osseuse/Globules Blancs marqués /Souffre colloïdal Dans le Diagnostic d'Une ostéomyélite du Pied ou de la Cheville</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetic foot osteomyelitis is a common and serious complication of diabetes. While the
      diagnosis of soft tissue infection can be made with simple physical examination in most
      cases, bone involvement can be harder to diagnose, often requiring medical imaging. In
      addition to conventional radiological examinations (x-ray and MRI) nuclear medicine
      procedures can also provide important physiological information in these patients. These
      procedures include triple phase bone scan combined with Gallium scintigraphy or a combination
      of labelled leukocyte scintigraphy and bone marrow scintigraphy using sulfur colloid. These
      procedure, while they provide useful physiological information, are time consuming, generally
      requiring at least 2 separate image acquisition on separate days, and can be costly.

      18F-FDG is a glucose analog that can be used for PET imaging. In addition to its application
      in oncology, the literature has shown that FDG can be used to investigate a wide variety of
      inflammatory and infectious conditions, including diabetic foot infections.

      The aim of this study is to compare the usefulness of FDG PET imaging versus &quot;conventional&quot;
      nuclear medicine (either bone scan and Gallium scintigraphy or labelled leukocytes and sulfur
      colloid scintigraphy) in patient with suspected diabetic foot osteomyelitis.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor patient recruitment
  </why_stopped>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">November 10, 2019</completion_date>
  <primary_completion_date type="Actual">November 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of 18F-FDG PET-CT for the diagnosis of diabetic foot osteomyelitis</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Diabetic Foot Infection</condition>
  <arm_group>
    <arm_group_label>Main arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PET-CT imaging of the ankles and feet following injection of 18F-FDG</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>18F-FDG PET-CT</intervention_name>
    <description>Patient will receive one injection of 18F-FDG and then undergo PET-CT imaging</description>
    <arm_group_label>Main arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetic patient with suspected diabetic foot osteomyelitis referred for nuclear
             medicine examination (bone scan and Gallium or labelled leukocytes).

          -  Being treated or followed by a physician at CHUM

        Exclusion Criteria:

          -  Pregnant woman

          -  Breastfeeding patient

          -  Claustrophobia/patient unable to complete imaging procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHUM</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>November 10, 2019</last_update_submitted>
  <last_update_submitted_qc>November 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

